Filing Details

Accession Number:
0001209191-14-002375
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-01-08 16:19:23
Reporting Period:
2014-01-06
Filing Date:
2014-01-08
Accepted Time:
2014-01-08 16:19:23
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
875320 Vertex Pharmaceuticals Inc / Ma VRTX Pharmaceutical Preparations (2834) 043039129
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1554979 E Megan Pace C/O Vertex Pharmaceuticals Incorporated
50 Northern Avenue
Boston MA 02210
Svp, Corp. Communications No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2014-01-06 838 $75.00 11,350 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. Transaction made pursuant to Ms. Pace's company approved trading plan under Rule 10b5-1.